Benjamin Haynor
Stock Analyst at Lake Street
(0.57)
# 4,123
Out of 5,179 analysts
14
Total ratings
30.77%
Success rate
-10.02%
Average return
Main Sectors:
Stocks Rated by Benjamin Haynor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FEMY Femasys | Initiates: Buy | $1.5 | $0.48 | +210.95% | 1 | Mar 3, 2026 | |
| PROF Profound Medical | Maintains: Buy | $11 → $12 | $6.19 | +93.86% | 2 | Jan 7, 2026 | |
| SRTA Strata Critical Medical | Assumes: Buy | $8 | $4.14 | +93.24% | 1 | Dec 2, 2025 | |
| INFU InfuSystem Holdings | Assumes: Buy | $15 | $9.54 | +57.23% | 1 | Sep 22, 2025 | |
| ELMD Electromed | Assumes: Buy | $36 | $24.55 | +46.64% | 1 | Aug 27, 2025 | |
| VSAT Viasat | Maintains: Buy | $31 → $19 | $46.58 | -59.21% | 5 | Sep 20, 2024 | |
| CGNT Cognyte Software | Downgrades: Hold | n/a | $7.75 | - | 2 | Mar 13, 2018 | |
| DRIO DarioHealth | Initiates: Buy | $1,400 | $8.11 | +17,162.64% | 1 | Aug 29, 2017 |
Femasys
Mar 3, 2026
Initiates: Buy
Price Target: $1.5
Current: $0.48
Upside: +210.95%
Profound Medical
Jan 7, 2026
Maintains: Buy
Price Target: $11 → $12
Current: $6.19
Upside: +93.86%
Strata Critical Medical
Dec 2, 2025
Assumes: Buy
Price Target: $8
Current: $4.14
Upside: +93.24%
InfuSystem Holdings
Sep 22, 2025
Assumes: Buy
Price Target: $15
Current: $9.54
Upside: +57.23%
Electromed
Aug 27, 2025
Assumes: Buy
Price Target: $36
Current: $24.55
Upside: +46.64%
Viasat
Sep 20, 2024
Maintains: Buy
Price Target: $31 → $19
Current: $46.58
Upside: -59.21%
Cognyte Software
Mar 13, 2018
Downgrades: Hold
Price Target: n/a
Current: $7.75
Upside: -
DarioHealth
Aug 29, 2017
Initiates: Buy
Price Target: $1,400
Current: $8.11
Upside: +17,162.64%